These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1181 related items for PubMed ID: 15990453

  • 1. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P, Totaro R, Contasta I, Berghella AM, Carolei A, Adorno D.
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 8. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis.
    Al-Shammri S, Rawoot P, Azizieh F, AbuQoora A, Hanna M, Saminathan TR, Raghupathy R.
    J Neurol Sci; 2004 Jul 15; 222(1-2):21-7. PubMed ID: 15240191
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G, Caielli S, Cutuli D, Falcone M.
    Immunology; 2007 Nov 15; 122(3):409-17. PubMed ID: 17617156
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y.
    Anticancer Res; 2006 Nov 15; 26(2A):1113-34. PubMed ID: 16619514
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy.
    Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P.
    Clin Exp Allergy; 1999 Jun 15; 29 Suppl 2():33-6. PubMed ID: 10421820
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F.
    Transfus Apher Sci; 2003 Aug 15; 29(1):61-70. PubMed ID: 12877896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I, König B, Böttcher I, Knop J, Saloga J.
    Clin Exp Allergy; 2006 Dec 15; 36(12):1546-55. PubMed ID: 17177678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.